A Two-part, Randomized, Double-blind, Single-dose, Crossover Study to Compare Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Adult Volunteers
Latest Information Update: 30 Jan 2023
At a glance
- Drugs Daprodustat (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 16 Jun 2021 Status changed from recruiting to completed.
- 26 Jan 2021 Planned End Date changed from 20 May 2021 to 21 May 2021.
- 26 Jan 2021 Planned primary completion date changed from 20 May 2021 to 21 May 2021.